The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...

Pfizer (PFE) has reportedly decided to sell its entire remaining stake in BioNTech (BNTX), showing a lack of confidence in ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

VLA15-221 Phase 2 study: strong immune response shown one month after a second booster dose (month 31) in pediatric and adult populations Significant anamnestic antibody response observed across all ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

WASHINGTON -- Pfizer announced Friday that it submitted a request to the U.S. Food and Drug Administration to allow emergency use of its COVID-19 vaccine to children as young as 12. This is the next ...

Pfizer CEO Albert Bourla said people will "likely" need a booster dose of a COVID-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1 ...

SAN FRANCISCO -- As more people are eligible to get vaccinated, reports of side effects after the second Pfizer and Moderna shots are surfacing. Dr. Robert Wachter, chief of medicine at UCSF says many ...